UroGen
UroGen is a New Jersey-based biotech company that develops and commercializes novel therapies for the treatment of cancer and urologic diseases.
Business Model:
Revenue: $62.4M
Employees: 51-200
Industries / Tags:
Detailed UroGen Information
Geographic Data
Address: 400 Alexander Park Drive
City: Princeton
State: NJ
Zip: 08540
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$100M
Raised Total:$233M
Social
Metrics
1,623,046Website Global Rank
14,923Website Monthly Traffic
Twitter Followers
Description
UroGen is a New Jersey-based biotech company that develops and commercializes novel therapies for the treatment of cancer and urologic diseases.
Contact Phone:
+16093674975
Contact Email:
UroGen went public on 5/5/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/5/2017
IPO Valuation:
$156M
Ticker Symbol:
URGN
IPO Price:
$13/share
Amount Raised:
$58M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | IPO | $58.2M | 5/2013 | Series A | 1 | $7M |
Pontifax Pontifax Pontifax Pontifax |
3/2021 | Post-IPO Equity | 1 | $75M |
RTW Investments LLC RTW Investments LLC |
3/2022 | Post-IPO Debt | 1 | $100M |
Pharmakon Advisors Pharmakon Advisors |
1/2018 | Post-IPO Equity | $60M | 11/2015 | Series A | 1 | $18M |
Two River Two River Two River Two River |
1/2019 | Post-IPO Equity | $162.1M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2015 | Telormedix |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
